Neurology Alert – August 1, 2009
August 1, 2009
View Issues
-
Interferon beta and Glatiramer Acetate: Equivalent for the Treatment of MS?
In an MRI-based study, interferon beta-1b failed to show superiority over glatiramer acetate for the treatment of multiple sclerosis. -
Erythromelalgia: Clinical Features, Effective Treatment with Carbamazepine
Carbamazepine is reported to be an effective symptomatic treatment for inherited erythromelalgia (IEM) due to the novel mutation of the Na(v)1.7 sodium channel, which is preferentially expressed in dorsal root ganglia. -
Why Is a Woman Different from a Man, at Least as Far as Stroke Risk?
An increased prevalence of atrial fibrillation leads to an increase in arterial territorial strokes in women. Hormonal risk factors are responsible for the increased risk of cerebral venous thrombosis in women, as compared to men. -
Sensory Neuronopathy: Diagnostic Criteria
Clinical criteria for sensory neuronopathy can reliably separate this syndrome from more distal, axonal syndromes. -
'Hardening of the Arteries' in the Central Nervous System in Scleroderma
Young patients with scleroderma, free of neurological symptoms, still show abnormalities in cognitive function and cerebrovascular reactivity. -
Autonomic Nervous System Dysfunction in PD with and without Dementia, and in Dementia with Lewy Bodies
The sequence of disease progression in Parkinson's disease (PD) and dementia with Lewy bodies (DLB) is different, with earlier limbic cortical involvement in DLB. Limbic cortical involvement may explain the more severe autonomic dysfunction that occurs in DLB and PD with dementia. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.